MYCi361
| CAS No. | 2289690-31-7 | Cat. No. | BCP34061 |
| Name | MYCi361 | ||
| Synonyms | MYCi-361;MYCi 361;NUCC-0196361;NUCC 0196361;NUCC0196361; | ||
| Formula | C26H16ClF9N2O2 | M. Wt | 594.86 |
| Description | MYCi361 is a MYC inhibitor with the Kd of 3.2 μM for binding to MYC. MYCi361 (NUCC-0196361) suppresses tumor growth and enhances anti-PD1 immunotherapy.MYCi361 inhibits the viability of MYC-dependent cancer cells including prostate cancer (MycCaP, LNCaP, and PC3), leukemia (MV4-11), lymphoma (HL-60 and P493-6), and neuroblastoma (SK-N-B2) with low-micromolar IC50 values. | ||
| Pathways | Apoptosis Pathway | ||
| Targets | c Myc | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.